Lower respiratory illness in infants and
โ
Robert S. Tepper; H. Eigen; J. Stevens; C. Angelicchio; J. Kisling; W. Ambrosius
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 30 KB
๐ 2 views
The purpose of our study was to assess the effect on pulmonary function of adding intravenous hydrocortisone to the standard treatment of infants with cystic fibrosis (CF) hospitalized for lower respiratory illnesses (LRI). Twenty CF infants were randomized and received 10 days of hydrocortisone (10